Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 30;12(9):e10741.
doi: 10.7759/cureus.10741.

Multiple System Atrophy - Cerebellar Type: Clinical Picture and Treatment of an Often-Overlooked Disorder

Affiliations
Review

Multiple System Atrophy - Cerebellar Type: Clinical Picture and Treatment of an Often-Overlooked Disorder

Juan Fernando Ortiz et al. Cureus. .

Abstract

Multiple system atrophy (MSA) is a rare, progressive, fatal, neurodegenerative disorder. There are two main types: the parkinsonian type (MSA-P) and cerebellar type (MSA-C). The disease usually presents with genitourinary dysfunction, orthostatic hypotension, and rapid eye movement (REM) sleep behavior disorder. Patients rapidly develop balance, speech, and coordination abnormalities. We present a review of the clinical picture and the actualized treatment modalities of the MSA cerebellar type. For the study methods, a PubMed search was done using the following medical subject headings (MeSH) terms: "multiple system atrophy/therapy". Inclusion criteria included studies in English, full papers, human studies, and publications in the last 30 years. Case reports and series were excluded. A total of 157 papers were extracted after applying the inclusion and exclusion criteria, and 41 papers were included for the discussion of this review. This review underlines the therapeutic strategies as well as the clinical picture of multiple system atrophy, and how MSA-C and MSA-P differ from each other. We discussed this review in four topics: ataxia, autonomic dysfunction (neurogenic orthostatic hypotension and urinary disorders), parkinsonism, and REM sleep disorder. In conclusion, the treatment of MSA-C is mainly symptomatic; there are not many studies on MSA-C. The ataxic component and fewer parkinsonian symptoms are the main difference of MSA-C as opposed to MSA-P.

Keywords: ataxia; autonomic dysfunction; multiple system atrophy; parkinsonism; sleep-wake disorder.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

Cited by

References

    1. Multiple system atrophy of the cerebellar type: clinical state of the art. Lin DJ, Hermann KL, Schmahmann JD. Mov Disord. 2014;29:294–304. - PubMed
    1. Multiple-system atrophy. Fanciulli A, Wenning GK. N Engl J Med. 2015;3:249–263. - PubMed
    1. Diagnosis of multiple system atrophy. Palma JA, Norcliffe-Kaufmann L, Kaufmann H. Auton Neurosci. 2018;211:15–25. - PMC - PubMed
    1. A cross-sectional study on drug use in multiple system atrophy. Rey MV, Perez-Lloret S, Pavy-Le Traon A, Meissner WG, Tison F, & Rascol O. CNS Drugs. 2014;28:483–490. - PubMed
    1. The natural history of multiple system atrophy: a prospective European cohort study. Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Köllensperger M, et al. Lancet Neurol. 2013;12:264–274. - PMC - PubMed

LinkOut - more resources